Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer

Mark Stephen Corbett; Jasmine Deng; Noortje Uphoff; Matthew James Walton; Joseph Lord; Helen Athena Fulbright; Kerry Dwan; Robert Hodgson

Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer

Mark Stephen Corbett, Jasmine Deng, Noortje Uphoff, Matthew James Walton, Joseph Lord, Helen Athena Fulbright, Kerry Dwan, Robert Hodgson^*

^*Corresponding author for this work

Centre for Reviews and Dissemination

Research output: Book/Report › Commissioned report

Original language	English
Publisher	National Institute for Health and Care Excellence
Commissioning body	National Institute for Health and Care Excellence
Publication status	Published - 7 Feb 2024

Access to Document

https://www.nice.org.uk/guidance/ta951/evidence/committee-papers-pdf-13309374349

Cite this

@book{a7b8d83319234a9eac8e105c574daf8a,

title = "Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer",

author = "Corbett, {Mark Stephen} and Jasmine Deng and Noortje Uphoff and Walton, {Matthew James} and Joseph Lord and Fulbright, {Helen Athena} and Kerry Dwan and Robert Hodgson",

year = "2024",

month = feb,

day = "7",

language = "English",

publisher = "National Institute for Health and Care Excellence",

}

TY - BOOK

T1 - Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer

AU - Corbett, Mark Stephen

AU - Deng, Jasmine

AU - Uphoff, Noortje

AU - Walton, Matthew James

AU - Lord, Joseph

AU - Fulbright, Helen Athena

AU - Dwan, Kerry

AU - Hodgson, Robert

PY - 2024/2/7

Y1 - 2024/2/7

M3 - Commissioned report

BT - Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer

PB - National Institute for Health and Care Excellence

ER -